ADVISORY SERVICES
Strategic Advisory for MedTech, R&D & Digital Health
Expert guidance for product and R&D transformations, strategic technology decisions, and technical due diligence for HealthTech executives and investors.
01 · PRODUCT STRATEGY
Product Strategy & Portfolio Transformation
Sharpening product vision, prioritizing roadmaps, and restructuring complex HealthTech portfolios to secure long-term market leadership.
- Product Vision & Roadmap Design
- Portfolio Analysis & Consolidation
- Time-to-Market Optimization
Typical Impact:
Risk mitigation in roadmap decisions and clear alignment of product management and R&D with market needs.
02 · R&D TRANSFORMATION
R&D Organization & Engineering
Modernizing R&D structures, driving agile adoption in regulated environments, and scaling global software and hardware teams.
- Agile Transformation in Regulated Environments
- Scaling Global R&D Teams
- Architecture & Interoperability
Typical Impact:
Shorter development cycles, higher software quality, and regulatory compliance (IEC 62304 / ISO 13485).
03 · DUE DILIGENCE
Technical Due Diligence & M&A Advisory
Rigorous technical evaluations of products, software architectures and R&D capabilities for investors and HealthTech buyers.
- R&D Team & Process Assessment
- Technology & Architecture Audits
- Cybersecurity & Compliance Checks
Typical Impact:
Critical risk identification prior to M&A transactions and actionable decision framework for PE and Corporate M&A.
04 · FRACTIONAL LEADERSHIP
Interim & Fractional Management (CTO, CPO, Head of R&D)
Execution-oriented leadership on demand. Experienced guidance during leadership transitions, restructuring, or scaling phases.
- Fractional CTO / CPO (Part-time leadership)
- Interim Head of R&D / VP Engineering
- Crisis & Restructuring Management
Typical Impact:
Immediate C-level leadership without headhunter delay, seamless transition management, and execution of critical milestones.
Planning a Strategic R&D or Product Initiative?
Let’s discuss your requirements and opportunities in a confidential initial consultation.